Neos Therapeutics, Inc. (NEOS) Social Stream

Featured Post From StockTwits About NEOS

$NEOS

3 Reasons Why You buy NEOS

1. NEOS, Turn a profit And Revenue Growth

Revenue of NEOS grew about eight times from $11M to $80M over five years from 2016 to 2020. And It is expected that NEOS will make a surplus in net profit in 2021.

2. ADHD Market Size Growth

The global ADHD market size was valued at USD 16.4 billion in 2018. ADHD Market Size Worth $24.9 Billion by 2025 | CAGR: 6.4%: Grand View Research, Inc. Neos Revenue and Income will grow

3. Merger with $AYTU

Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue Specialty Pharmaceutical Company Aytu adds Neos’ established, multi-brand ADHD portfolio, enhancing Aytu’s footprint in pediatrics and expanding its presence in adjacent specialty care segments

$TSLA $GME $AMCX

What Else are NEOS Traders Talking About?

Other tickers frequently mentioned alongside NEOS are AYTU, GME and AMCX.